New-generation JAK inhibitors: how selective can they be?

Lancet. 2018 Jun 23;391(10139):2477-2478. doi: 10.1016/S0140-6736(18)31325-4. Epub 2018 Jun 13.

Authors

Guro L Goll¹, Tore K Kvien²

Affiliations

¹ Department of Rheumatology, Diakonhjemmet Hospital, N-0319 Oslo, Norway.
² Department of Rheumatology, Diakonhjemmet Hospital, N-0319 Oslo, Norway. Electronic address: t.k.kvien@medisin.uio.no.

PMID: 29908671
DOI: 10.1016/S0140-6736(18)31325-4

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antirheumatic Agents
Arthritis, Rheumatoid
Double-Blind Method*
Humans
Janus Kinase Inhibitors*
Janus Kinases
Protein Kinase Inhibitors

Substances

Antirheumatic Agents
Janus Kinase Inhibitors
Protein Kinase Inhibitors
Janus Kinases